tak-228
Showing 1 - 7 of 7
Soft-tissue Sarcoma Trial in Philadelphia (TAK-228)
Terminated
- Soft-tissue Sarcoma
- TAK-228
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Sep 19, 2022
Advanced Solid Tumor Trial in Sioux Falls (paclitaxel, TAK-228, TAK-117)
Active, not recruiting
- Advanced Solid Tumor
- paclitaxel
- +2 more
-
Sioux Falls, South DakotaAvera Cancer Institute
Aug 24, 2021
Estrogen Receptor Positive Breast Cancer Trial in Houston, Sugar Land (TAK-228, Tamoxifen)
Completed
- Estrogen Receptor Positive Breast Cancer
- TAK-228
- Tamoxifen
-
Houston, Texas
- +2 more
Aug 27, 2021
Advanced Nonhematological Tumors Trial in Japan, Korea, Republic of, Taiwan (TAK-228)
Terminated
- Advanced Nonhematological Neoplasms
- TAK-228
-
Kashiwa-shi, Chiba-Ken, Japan
- +3 more
Apr 22, 2021
Breast Cancer Trial in Lebanon (TAK-228, Letrozole)
Withdrawn
- Breast Cancer
- TAK-228
- Letrozole
-
Lebanon, New HampshireDartmouth Hitchcock Medical Center
Mar 10, 2020
Advanced Nonhematologic Malignancies Trial in Spain, United Kingdom, United States (TAK-228, TAK-117)
Completed
- Advanced Nonhematologic Malignancies
- TAK-228
- TAK-117
-
Boston, Massachusetts
- +4 more
Oct 7, 2019
Malignant Tumors of Digestive Organs, Malignant Tumors of Female Genital Organs, Malignant Tumors of Lip Oral Cavity and Pharynx
Withdrawn
- Malignant Neoplasms of Digestive Organs
- +3 more
- Alisertib
- TAK-228
- (no location specified)
Mar 24, 2017